82 studies found for:    vaccine adverse reactions | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults
Condition: Influenza, Human
Interventions: Drug: Intanza;   Drug: Vaxigrip
22 Unknown  Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis Patients
Condition: Influenza
Intervention: Drug: AdimFlu-S
23 Recruiting αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies
Conditions: Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface;   Malignant Peritoneal Mesothelioma;   Peritoneal Carcinomatosis
Interventions: Biological: DC vaccine;   Drug: Celecoxib;   Drug: Interferon Alfa-2b;   Biological: rintatolimod
24 Not yet recruiting Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine Administered by Aerosol
Condition: Tuberculosis
Intervention: Biological: Ad5Ag85A
25 Recruiting Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Chronic Myeloid Leukemia;   Non Hodgkin's Lymphoma;   Hodgkin's Disease;   Myelodysplastic Syndrome;   Multiple Myeloma;   Aplastic Anemia
Intervention: Biological: allogeneic donor derived B-lymphocytes
26 Unknown  The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants
Conditions: Immunity;   Measles;   Mumps;   Rubella
Interventions: Dietary Supplement: Probiotics (L.acidophilus and B.lactis);   Dietary Supplement: Cornflor
27 Unknown  Safety Study of Recombinant Listeria Monocytogenes(Lm)Based Vaccine Virus Vaccine to Treat Oropharyngeal Cancer
Condition: HPV-16 +ve Oropharyngeal Carcinoma
Intervention: Biological: ADXS11-001
28 Not yet recruiting Polysaccharide Antibody Response Study
Condition: Specific Polysaccharide Antibody Deficiency
Interventions: Biological: Pneumovax 23 (Sanofi Pasteur MSD);   Biological: Typhim Vi (Sanofi Pasteur MSD)
29 Recruiting An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate
Condition: Rhematoid Arthritis
Interventions: Drug: Tofacitinib with methotrexate;   Drug: Tofacitinib without methotrexate;   Biological: Adalimumab with methotrexate
30 Recruiting Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector
Condition: Severe Combined Immunodeficiency
Intervention: Biological: Gene transfer
31 Unknown  Modulation of Immune Response by Oral Zinc Supplementation in Chemotherapy for Colon Cancer
Conditions: Adjuvant Chemotherapy;   Colon Cancer;   Immunity
Interventions: Dietary Supplement: zinc;   Other: Placebo
32 Recruiting Do Some Healthy Adults Consistently Have Systemic Reactions to Influenza Vaccines?
Condition: Influenza
Intervention: Biological: Vaccine
33 Not yet recruiting ID Recombinant Ricin Toxin A-Chain Vaccine RVEc™ — 3-Dose Primary Series With Boost
Condition: Ricin Poisoning
Intervention: Biological: RVEc
34 Not yet recruiting IM Recombinant Ricin Toxin Vaccine (RVEc) — 3-Dose Primary Series With Boost
Condition: Ricin Poisoning
Intervention: Biological: RVEc
35 Recruiting Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide
Condition: B-cell Chronic Lymphocytic Leukemia
Interventions: Biological: B-CLL Vaccine;   Drug: Lenalidomide
36 Unknown  A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso
Condition: Malaria
Interventions: Biological: MSP 3 Long Synthetic Peptide;   Biological: Hepatitis B vaccine;   Biological: Hepatitis B control vaccince
37 Recruiting Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants
Condition: Pneumococcal Disease
Interventions: Biological: SIILPCV10;   Biological: Pneumovax 23;   Biological: Prevenar 13
38 Not yet recruiting Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects
Condition: Tuberculosis
Interventions: Biological: ID93;   Biological: GLA-SE;   Other: AP10-602
39 Unknown  Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])
Condition: Malaria
Interventions: Biological: Malaria vaccine AMA1 (PfAMA-1-FVO[25-545];   Biological: AMA1
40 Recruiting Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection
Condition: Clostridium Difficile Infection
Interventions: Biological: C. difficile Toxoid Vaccine;   Biological: Placebo: 0.9% normal saline

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years